Grünenthal's Palexia SR launched in UK
This article was originally published in Scrip
German based Grünenthal has launched its first in class pain killer, Palexia SR (tapentadol prolonged release), in the UK on 16 May 2011.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.